Newomics

About:

Newomics commercializes innovative and integrative platforms and solutions for personalized healthcare.

Website: https://www.newomics.com/

Twitter/X: NewomicsInc

Top Investors: LDV Partners, Berkeley Catalyst Fund (BCF), Photon Fund

Description:

Newomics is an early stage biotechnology company that commercializes innovative and integrative platforms and solutions for personalized healthcare. Its proprietary technology is based on silicon-microfluidic-chip for liquid chromatography-mass spectrometry (LC-MS) and offers unprecedented robustness, sensitivity, specificity, and throughput for analyzing molecules from minute amounts of biospecimens such as blood and urine.

Total Funding Amount:

$15.7M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Berkeley, California, United States

Founded Date:

2018-01-01

Founders:

Daojing Wang

Number of Employees:

11-50

Last Funding Date:

2020-12-01

IPO Status:

Private

Industries:

© 2025 bioDAO.ai